Filing Flows

Filing Flows › 8-K events › Rafael Holdings

Rafael Holdings: results of operations

Form 8-K filed Oct 29, 2026 · items 2.02, 7.01, 8.01

FDA decisionsRafael Holdings Reports Fourth Quarter and Full Year Fiscal 2026

What the filing says

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2026 Rafael Holdings, Inc. (NYSE: RFL) today reported its financial results for the fourth quarter and full fiscal year 2026 ended July 31, 2026.

Read the filing on SEC EDGAR →

What usually followsAcross 69,115 8-Ks reporting Item 2.02 (results of operations) in our universe, the stock's median move the next session was +0.2% (typical size ±3.6%, up 51% of the time); over the following 21 sessions, +1.2%. Item 8.01: +0.1% next session across 44,881. Every item ranked →

Rafael Holdings at a glance

Latest quarterQ4 FY26
Revenue$244K
Revenue Y/Y-30%
Operating marginn/m
IndustryPharmaceutical Preparations

Rafael Holdings, Q4 FY26: revenue $244K (-30% year over year). The chart follows the revenue to costs, profit and cash.

Rafael Holdings: every quarter, Q/Q and Y/Y, holders and guidance →

Other recent fda decisions

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.